FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073049319> ?p ?o ?g. }

• W2073049319 endingPage "6148" @default.
• W2073049319 startingPage "6148" @default.
• W2073049319 abstract "To investigate whether activated carbon nanoparticles suspension (ACNS) or methylene blue (MB) can increase the detected number of lymph nodes in colorectal cancer.Sixty-seven of 72 colorectal cancer patients treated at our hospital fulfilled the inclusion criteria of the study which was conducted from December 2010 to February 2012. Seven patients refused to participate. Eventually, 60 patients were included, and randomly assigned to three groups (20 in each group): ACNS group (group A), MB group (group B) and non-stained conventional surgical group (group C). In group A, patients received subserosal injection of 1 mL ACNS in a 4-quadrant region around the mass. In group B, the main artery of specimen was identified and isolated after the specimen was removed, and 2 mL MB was slowly injected into the isolated, stretched and fixed vessel. In group C, no ACNS and MB were injected. All the mesentery lymph nodes were isolated and removed systematically by visually inspecting and palpating the adipose tissue.No difference was observed among the three groups in age, gender, tumor location, tumor diameter, T-stage, degree of differentiation, postoperative complications and peritoneal drainage retention time. The total number of detected lymph nodes was 535, 476 and 223 in the three groups, respectively. The mean number of detected lymph nodes per patient was significantly higher in group A than in group C (26.8 ± 8.4 vs 12.2 ± 3.2, P < 0.001). Similarly, there were significantly more lymph nodes detected in group B than in group C (23.8 ± 6.9 vs 12.2 ± 3.2, P < 0.001). However, there was no significant difference between group A and group B. There were 50, 46 and 32 metastatic lymph nodes dissected in 13 patients of group A, 10 patients of group B and 11 patients of group C, without significant differences among the three groups. Eleven of the 60 patients had insufficient number of detected lymph nodes (< 12). Only one patient with T(4a) rectal cancer had 10 lymph nodes detected in group B, the other 10 patients were all from group C. Based on the different diameter categories, the number of detected lymph nodes in groups A and B was significantly higher than in group C. However, there was no statistically significant difference between group A and group B. The metastatic lymph nodes were not significant different among the three groups. Similarly, tumor location, T stage and tumor differentiation did not affect the staining results. Body mass index was a minor influencing factor in the two different staining methods. The stained lymph nodes can easily be identified from the mesenteric adipose tissues, and the staining time for lymph nodes was not significantly different compared with unstained group. None of the patients in groups A and B had drug-related complications.Both activated carbon nanoparticles suspension in vivo and methylene blue in vitro can be used as tracers to increase the detected number of lymph nodes in colorectal cancer." @default.
• W2073049319 created "2016-06-24" @default.
• W2073049319 creator A5025075819 @default.
• W2073049319 creator A5041654056 @default.
• W2073049319 creator A5053805287 @default.
• W2073049319 creator A5078584694 @default.
• W2073049319 creator A5083027530 @default.
• W2073049319 creator A5084343692 @default.
• W2073049319 date "2012-01-01" @default.
• W2073049319 modified "2023-09-30" @default.
• W2073049319 title "Colorectal cancer lymph node staining by activated carbon nanoparticles suspension<i>in vivo</i>or methylene blue<i>in vitro</i>" @default.
• W2073049319 cites W1965654346 @default.
• W2073049319 cites W1971250194 @default.
• W2073049319 cites W1971679316 @default.
• W2073049319 cites W1973102929 @default.
• W2073049319 cites W1973454986 @default.
• W2073049319 cites W1979046723 @default.
• W2073049319 cites W1984349400 @default.
• W2073049319 cites W1985213644 @default.
• W2073049319 cites W1991001075 @default.
• W2073049319 cites W1993965603 @default.
• W2073049319 cites W2003261841 @default.
• W2073049319 cites W2017947769 @default.
• W2073049319 cites W2020478492 @default.
• W2073049319 cites W2025034053 @default.
• W2073049319 cites W2027656652 @default.
• W2073049319 cites W2034045987 @default.
• W2073049319 cites W2038993108 @default.
• W2073049319 cites W2043029825 @default.
• W2073049319 cites W2044758573 @default.
• W2073049319 cites W2047122748 @default.
• W2073049319 cites W2051568530 @default.
• W2073049319 cites W2088536552 @default.
• W2073049319 cites W2099941122 @default.
• W2073049319 cites W2112966923 @default.
• W2073049319 cites W2119579595 @default.
• W2073049319 cites W2126116106 @default.
• W2073049319 cites W2128696928 @default.
• W2073049319 cites W2136418036 @default.
• W2073049319 cites W2153017356 @default.
• W2073049319 cites W2153901847 @default.
• W2073049319 cites W2157164206 @default.
• W2073049319 cites W2163737002 @default.
• W2073049319 cites W2165643303 @default.
• W2073049319 cites W2165948908 @default.
• W2073049319 cites W2167299806 @default.
• W2073049319 cites W2168608079 @default.
• W2073049319 cites W2326634845 @default.
• W2073049319 doi "https://doi.org/10.3748/wjg.v18.i42.6148" @default.
• W2073049319 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3496893" @default.
• W2073049319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23155345" @default.
• W2073049319 hasPublicationYear "2012" @default.
• W2073049319 type Work @default.
• W2073049319 sameAs 2073049319 @default.
• W2073049319 citedByCount "54" @default.
• W2073049319 countsByYear W20730493192013 @default.
• W2073049319 countsByYear W20730493192015 @default.
• W2073049319 countsByYear W20730493192016 @default.
• W2073049319 countsByYear W20730493192017 @default.
• W2073049319 countsByYear W20730493192018 @default.
• W2073049319 countsByYear W20730493192019 @default.
• W2073049319 countsByYear W20730493192020 @default.
• W2073049319 countsByYear W20730493192021 @default.
• W2073049319 countsByYear W20730493192022 @default.
• W2073049319 countsByYear W20730493192023 @default.
• W2073049319 crossrefType "journal-article" @default.
• W2073049319 hasAuthorship W2073049319A5025075819 @default.
• W2073049319 hasAuthorship W2073049319A5041654056 @default.
• W2073049319 hasAuthorship W2073049319A5053805287 @default.
• W2073049319 hasAuthorship W2073049319A5078584694 @default.
• W2073049319 hasAuthorship W2073049319A5083027530 @default.
• W2073049319 hasAuthorship W2073049319A5084343692 @default.
• W2073049319 hasBestOaLocation W20730493191 @default.
• W2073049319 hasConcept C121608353 @default.
• W2073049319 hasConcept C125473707 @default.
• W2073049319 hasConcept C126322002 @default.
• W2073049319 hasConcept C126894567 @default.
• W2073049319 hasConcept C141071460 @default.
• W2073049319 hasConcept C142724271 @default.
• W2073049319 hasConcept C150903083 @default.
• W2073049319 hasConcept C207001950 @default.
• W2073049319 hasConcept C2777785397 @default.
• W2073049319 hasConcept C2779720271 @default.
• W2073049319 hasConcept C2780678043 @default.
• W2073049319 hasConcept C2780849966 @default.
• W2073049319 hasConcept C526805850 @default.
• W2073049319 hasConcept C71924100 @default.
• W2073049319 hasConcept C74864618 @default.
• W2073049319 hasConcept C86803240 @default.
• W2073049319 hasConcept C90924648 @default.
• W2073049319 hasConceptScore W2073049319C121608353 @default.
• W2073049319 hasConceptScore W2073049319C125473707 @default.
• W2073049319 hasConceptScore W2073049319C126322002 @default.
• W2073049319 hasConceptScore W2073049319C126894567 @default.
• W2073049319 hasConceptScore W2073049319C141071460 @default.
• W2073049319 hasConceptScore W2073049319C142724271 @default.
• W2073049319 hasConceptScore W2073049319C150903083 @default.
• W2073049319 hasConceptScore W2073049319C207001950 @default.

• next